您当前的位置:
首页 >
文章列表页 >
Clinical application study on malignant metastatic diseases between DWIBS and PET/CT
更新时间:2025-12-31
    • Clinical application study on malignant metastatic diseases between DWIBS and PET/CT

    • China Oncology   Vol. 25, Issue 6, Pages: 457-467(2015)
    • DOI:10.3969/j.issn.1007-3969.2015.06.009    

      CLC:
    • Published Online:14 August 2015

      Published:14 August 2015

    移动端阅览

  • 沈茜刚, 周良平, 彭卫军. Clinical application study on malignant metastatic diseases between DWIBS and PET/CT[J]. China Oncology, 2015, 25(6): 457-467. DOI: 10.3969/j.issn.1007-3969.2015.06.009.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

2781

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The epigenetic regulation of histone methyltransferase SET8 in cancer
Research progress on the regulation of tumor malignancy by lactate
Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
Research progress and prospects on the mechanisms of circulating tumor cells in the invasion and metastasis of cholangiocarcinoma
Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

Related Author

申雪芳
许平波
Zhiling WANG
Wanjin CHEN
Shengtao CHENG
Ximei ZHANG
Yixuan ZHOU

Related Institution

复旦大学附属肿瘤医院麻醉科,复旦大学上海医学院肿瘤学系
The Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education, Chongqing Medical University
Department of Maxillofacial Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Key Laboratory of Oral and Maxillofacial Functional Reconstruction
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
0